Bullous Keratopathy

0
Pipeline Programs
1
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Alcon
AlconFORT WORTH, TX
2 programs
Lotrafilcon A contact lensesN/A1 trial
Lotrafilcon A contact lensesN/A1 trial
Active Trials
NCT05956535CompletedEst. Oct 2024
NCT05891106Completed55Est. Jul 2023

Trial Timeline

Clinical trial activity over time

2023
2024
2025
2026
AlconLotrafilcon A contact lenses
AlconLotrafilcon A contact lenses

Clinical Trials (2)

Total enrollment: 55 patients across 2 trials

NCT05956535AlconLotrafilcon A contact lenses

Air Optix® Night and Day® Aqua Therapeutic Wear

Start: Sep 2023Est. completion: Oct 2024
N/ACompleted
NCT05891106AlconLotrafilcon A contact lenses

AONDA Therapeutic Indication Study I

Start: Jun 2023Est. completion: Jul 202355 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space